Susceptibility and resistance to canine leishmaniose is associated to polymorphisms of the canine TNF-α gene

European Journal of Inflammation

Volumn 9, Issue 1, 2011, Pages 23-29

  Symeonidou, Isaia ^a   Hatzistilianou, M ^b   Papadopoulos, E ^a   Dovas, C I ^a   Karagouni, E ^c   Pappa, S ^b   Pantzartzi, C N ^d   Kourelis, A ^d   Frydas, S ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c HELLENIC PASTEUR INSTITUTE   (Greece)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Canine leishmaniasis; Resistance; SNPs; Susceptibility; TNF

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ELECTROPHORESIS; LEISHMANIASIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYMERASE CHAIN REACTION; SEX DIFFERENCE;

EID: 81755169964     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X1100900104     Document Type: Article

References (23)

1. Baneth G, Koutinas AF, Solano-Gallego L, Bourdeau P, Ferrer L. Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one. Trends Parasitol 2008; 24:324-30.
2. Solano-Gallego L, Koutinas A, Miro G, Cardoso L, Pennisi MG, Ferrer L, Bourdeau P, Oliva G, Baneth G. Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis. Vet Parasitol 2009; 165:1-18.
3. Baneth G. Leishmaniasis, in Greene G (ed): Infectious Diseases of the Dog and Cat, 3rd ed. Saunders company, Philadelphia, 2005, pp 685-95.
4. Koutinas AF, Polizopoulou ZS, Saridomichelakis MN, Argyriadis D, Fytianou A, Plevraki KG. Clinical considerations on canine visceral leishmaniasis in Greece: a retrospective study of 158 cases (1989-1996). J Am Anim Hosp Assoc 1999; 35:376-83. (Pubitemid 129566798)
5. Blavier A, Keroack S, Denerolle P, Goy-Thollot I, Chabanne L, Cadore JL, Bourdoiseau G. Atypical forms of canine leishmaniosis. Vet J 2001; 162:108-20. (Pubitemid 33651609)
6. Alvar J, Canavate C, Molina R, Moreno J, Nieto J. Canine leishmaniasis. Adv Parasitol 2004; 57:1-88. (Pubitemid 39422432)
7. Barbieri CL. Immunology of canine leishmaniasis. Parasite Immunol 2006; 28:329-37. (Pubitemid 43967397)
8. Pinelli E, Killick-Kendrick R, Wagenaar J, Bernadina W, del Real G, Ruitenberg J. Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum. Infect Immun 1994; 62:229-35. (Pubitemid 24011964)
9. Strauss-Ayali D, Baneth G, Jaffe CL. Splenic immune responses during canine visceral leishmaniasis. Vet Res 2007; 38:547-64. (Pubitemid 47282166)
10. Elahi MM, Asotra K, Matata BM, Mastana SS. Tumor necrosis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochim Biophys Acta 2009; 1792:163-72.
11. Ware CF. The TNF Superfamily-2008. Cytokine Growth Factor Rev 2008; 19:183-6. (Pubitemid 351794570)
12. Engwerda CR, Ato M, Stager S, Alexander CE, Stanley AC, Kaye PM. Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection. Am J Pathol 2004; 165:2123-33. (Pubitemid 39578389)
13. Murray HW, Jungbluth A, Ritter E, Montelibano C, Marino MW. Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment. Infect Immun 2000; 68:6289-93.
14. Wilhelm P, Ritter U, Labbow S, Donhauser N, Rollinghoff M, Bogdan C, Korner H. Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J Immunol 2001; 166:4012-9. (Pubitemid 32224930)
15. Garnier-Gere P, Dillmann C. A computer program for testing pairwise linkage disequilibria in subdivided populations. J Hered 1992; 83:239.
16. Beutler BA. The role of tumor necrosis factor in health and disease. J Rheumatol Suppl 1999; 57:16-21. (Pubitemid 29210245)
17. Chamizo C, Moreno J, Alvar J. Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis. Vet Immunol Immunopathol 2005; 103:67-75. (Pubitemid 40038222)
18. de Lima VM, Peiro JR, de Oliveira Vasconcelos R. IL-6 and TNF-alpha production during active canine visceral leishmaniasis. Vet Immunol Immunopathol 2007; 115:189-93. (Pubitemid 44908674)
19. Alves CF, de Amorim IF, Moura EP, et al. Expression of IFN-gamma, TNF-alpha, IL-10 and TGF-beta in lymph nodes associates with parasite load and clinical form of disease in dogs naturally infected with Leishmania (Leishmania) chagasi. Vet Immunol Immunopathol 2009; 128:349-58.
20. Abraham LJ, Kroeger KM. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 1999; 66:562-6. (Pubitemid 29489880)
21. Stepanova M, Tiazhelova T, Skoblov M, Baranova A. Potential regulatory SNPs in promoters of human genes: a systematic approach. Mol Cell Probes 2006; 20:348-58. (Pubitemid 44479823)
22. Aguillon JC, Cruzat A, Cuenca J, Cuchacovich M. [Tumor necrosis factor alpha genetic polymorphism as a risk factor in disease]. Rev Med Chil 2002; 130:1043-50.
23. Warle MC, Farhan A, Metselaar HJ, et al. Are cytokine gene polymorphisms related to in vitro cytokine production profiles? Liver Transpl 2003; 9:170-81. (Pubitemid 36204567)